zepbound tirzepatide alternatives weight loss Eli Lilly sues companies selling alternative versions of its drug : Shots Zepbound (Tirzepatide) Injections for Weight

An observational study published in 2023 in Diabetes Care that looked to determine whether the use of GLP-1 medications was associated with an increased risk of thyroid cancer found that in 1-3 years of treatment, the risk for thyroid cancer was increased for those taking GLP-1 medications (2)

If youre an athleisure brand or a department store with a broad size assortment, youre probably going to see tailwinds right now

Wipe the rubber seal with an alcohol swab then attach a new needle

Well, both Eli Lilly and Novo Nordisk have direct-to-consumer programs at around $500 per month, and theyre being utilized

Both are available across all 50 states without insurance or membership fees, and HSA/FSA accounts are eligible